TCT 58: Successful Prediction of LVEF Recovery after PCI Using Invasive Coronary Physiologic Indices

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker’s Bureau - Abbott Vascular; Biotronik; Medtronic
• Equity/Stock(s)/Options - Heartbeam